125Iodine prostate brachytherapy: Outcome from the first 100 consecutive patients and selection strategies incorporating urodynamics

BJU International

Volumn 90, Issue 6, 2002, Pages 567-572

  Henderson, A ^a,b   Cahill, D ^a   Laing, R W ^a   Langley, S E M ^a  

^a St Luke's Cancer Centre   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

Brachytherapy; Clean intermittent self catheterization; IPSS; Prostate cancer; Urodynamics

Indexed keywords

ALFUZOSIN; BICALUTAMIDE; GONADORELIN DERIVATIVE; IODINE 125; RAPIDSTRAND;

ADULT; AGED; ARTICLE; BLADDER NECK STENOSIS; BLADDER SURGERY; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SCREENING; CATHETERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FOLLOW UP; HUMAN; IMPLANTATION; INTERSTITIAL RADIATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; ORGAN SIZE; PATIENT SELECTION; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; PROCTITIS; PROSTATE CANCER; RADIOISOTOPE THERAPY; RECTUM DISEASE; RISK ASSESSMENT; SAFETY; SCORING SYSTEM; SCREENING TEST; STATISTICAL SIGNIFICANCE; SYMPTOM; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT OUTCOME; URETHRA DISEASE; URINE RETENTION; URODYNAMICS; UROFLOWMETRY;

AGED; BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; LOGISTIC MODELS; MALE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; RISK FACTORS; SELF CARE; TREATMENT OUTCOME; URINARY CATHETERIZATION; URODYNAMICS;

EID: 0036378425     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2002.02983.x     Document Type: Article

References (18)

1. Ragde H, Korb LJ, Elgamal AA, Grado GL, Nadir BS. Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up. Cancer 2000; 89: 135-41
2. Blasko JC, Grimm PD, Sylvester JE, Badiozamani KR, Hoak D, Cavanagh W. Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 2000; 46: 839-50
3. Grimm PD, Blasko JC, Sylvester JE, Meier RM, Cavanagh W. 10-year biochemical (prostate-specific antigen) control of prostate cancer with 125, I brachytherapy. Int J Radiat Oncol Biol Phys 2001; 51: 31-40
4. Langley SEM, Laing RW. Prostate brachytherapy has come of age: a review of the technique and results. BJU Int 2002; 89: 1-14
5. Terk MD, Stock RG, Stone NN. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 1998; 160: 1379-82
6. Dattoli M, Wallner K, Sorace R et al. 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma. Int J Radiat Oncol Biol Phys 1996; 35: 875-9
7. Wagner TT, Nag S, Young D, Bahnson RR. Early voiding dysfunction associated with prostate brachytherapy. Urol Oncol 2000; 6: 20-3
8. Lee N, Wuu CS, Brody R et al. Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2000; 48: 1457-60
9. Wadie BS, Ibrahim EH, de la Rosette JJ, Gomha MA, Ghoneim MA. The relationship of the International Prostate Symptom Score and objective parameters for diagnosing bladder outlet obstruction. Part I: when statistics fail. J Urol 2001; 165: 32-4
10. Ash D, Flynn A, Battermann J, de Reijke T, Lavagnini P, Blank L. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 2000; 57: 315-21
11. Desai J, Stock RG, Stone NN, Iannuzzi C, DeWyngaert JK. Acute urinary morbidity following I-125 interstitial implantation of the prostate gland. Radiat Oncol Invest 1998; 6: 135-41
12. Merrick GS, Butler WM, Lief JH, Dorsey AT. Temporal resolution of urinary morbidity following prostate brachytherapy. Int J Radiat Oncol Biol Phys 2000; 47: 121-8
13. Abrams P. Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int 1999; 84: 14-5
14. Patel MI, Watts W, Grant A. The optimal form of urinary drainage after acute retention of urine. BJU Int 2001; 88: 26-9
15. Badiozamani KR, Wallner K, Sutlief S, Ellis W, Blasko J, Russell K. Anticipating prostatic volume changes due to prostate brachytherapy. Radiat Oncol Invest 1999; 7: 360-4
16. Lee WR, Hall MC, McQuellon RP, Case LD, McCullough DL. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy. Int J Radiat Oncol Biol Phys 2001; 51: 614-23
17. Kumar VMC, Hough C, Javle P. Impact of radical prostatectomy on LUTS and quality of life. BJU Int 2001; 88 (Suppl. 1): 49
18. Schwartz EJ, Lepor H. Radical retropubic prostatectomy reduces symptom scores and improves quality of life in men with moderate and severe lower urinary tract symptoms. J Urol 1999; 161: 1185-8